An Epigenetic Mitotic Score Tracks the Proliferative History and Capacity of CLL Samples at Diagnosis and Is Associated with Clinical Outcome

dc.contributor.author	Duran-Ferrer, Martí
dc.contributor.author	Nadeu, Ferrán
dc.contributor.author	Clot, Guillem
dc.contributor.author	Suárez Puente, Xosé Antón
dc.contributor.author	López Otín, Carlos
dc.date.accessioned	2019-08-21T07:34:01Z
dc.date.available	2019-08-21T07:34:01Z
dc.date.issued	2018
dc.identifier.issn	0006-4971
dc.identifier.issn	1528-0020
dc.identifier.uri	http://hdl.handle.net/10651/52194
dc.description	American Society of Hematology (ASH) Annual Meeting Abstracts (60th, 2018, San Diego, USA)
dc.description.statementofresponsibility	Duran-Ferrer, M., Nadeu, F., Clot, G., Beekman, R., Baumann, T., Lopez-Guillermo, A., Delgado, J., Puente, X., Lopez-Otin, C., Campo, E., Subero, IM.
dc.format.extent	p. 1842-
dc.language.iso	eng
dc.relation.ispartof	Blood, 132(S1)
dc.rights	© 2018 by The American Society of Hematology
dc.source	WOS:000454837605196
dc.title	An Epigenetic Mitotic Score Tracks the Proliferative History and Capacity of CLL Samples at Diagnosis and Is Associated with Clinical Outcome
dc.type	conference output	spa
dc.identifier.doi	10.1182/blood-2018-99-113434
dc.relation.publisherversion	http://dx.doi.org/10.1182/blood-2018-99-113434

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.